Expression of class I major histocompatibility complex antigens in Epstein-Barr virus-carrying lymphoblastoid cell lines and Burkitt lymphoma cells by Jilg, W. et al.
  
 1991;51:27-32. Published online January 1, 1991.Cancer Res
 
Wolfgang Jilg, Raymond Voltz, Christine Markert-Hahn, et al.
 
Lines and Burkitt Lymphoma Cells
Antigens in Epstein-Barr Virus-carrying Lymphoblastoid Cell 
Expression of Class I Major Histocompatibility Complex
 
 
 
 
Updated Version
 http://cancerres.aacrjournals.org/content/51/1/27
Access the most recent version of this article at: 
 
 
Citing Articles
 http://cancerres.aacrjournals.org/content/51/1/27#related-urls
This article has been cited by 1 HighWire-hosted articles. Access the articles at:
 
 
E-mail alerts  related to this article or journal.Sign up to receive free email-alerts
Subscriptions
Reprints and
.pubs@aacr.orgDepartment at
To order reprints of this article or to subscribe to the journal, contact the AACR Publications
Permissions
.permissions@aacr.orgDepartment at 
To request permission to re-use all or part of this article, contact the AACR Publications
 American Association for Cancer Research Copyright © 1991 
 on April 11, 2011cancerres.aacrjournals.orgDownloaded from 
(CANCER RESEARCH 51, 27-32, January. 1991]
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Virus-carrying Lymphoblastoid Cell Lines and Burkitt Lymphoma Cells1
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Max von Pellenkofer-lnslitute for Hygiene and Medical Microbiology, University of Munich, Munich, Federal Republic of Germany
ABSTRACT
Epstein-Barr virus (EBV) carrying lymphoblastoid cell lines (LCLs)
and EBV-positive Burkitt lymphoma (BL) cells were compared for their
expression of class I antigens of the major histocompatibility complex.
Five common BL lines, LCLs, pokeweed mitogen-stimulated blasts and
resting B-cells from healthy donors, and eight pairs of BL cells and
LCLs, each pair originating from one patient, were tested. Quantitative
analysis was performed using a radioimmunoassay; qualitative aspects
were studied by one- and two-dimensional gel electrophoresis. In general,
LCLs expressed significantly higher amounts of class I antigens than BL
cells, the latter showing class I densities similar to or lower than periph
eral resting B-cells. From analysis of the expression of class I-specific
RNA, there is some evidence that class I antigen expression is regulated
on the transcriptional level. In two BL cells studied, class I expression
could be enhanced by 7-interferon, whereas the corresponding LCLs
seemed to be refractory to this treatment. One- and two-dimensional gel
electrophoresis showed that in some BL lines, in addition to the generally
lower class I expression, distinct class I specificities were down-regulated.
None of these alterations in class I expression was EBV specific; however,
they may well play a role in the recognition of BL cells and LCLs by
cellular immune mechanisms. Thus, down-regulation of class I antigens
may contribute to the resistance of BL cells to cytotoxic T-lymphocytes,
whereas their enhanced expression may improve the recognition of EBV-
infected LCLs.
INTRODUCTION
From EBV3 infected B-lymphocytes LCLs with indefinite
growth potential can be established in vitro. In the healthy
EBV-positive individual, however, these cells are efficiently
controlled by specific CTL restricted by class I antigens of the
MHC (1). EBV-carrying BL cells, on the other hand, can escape
this immune surveillance, although BL patients possess CTL
reacting against their normal EBV-infected B-lymphocytes (2);
in vitro experiments showed that most BL cells are indeed
resistant to HLA-matched EBV-specific CTL (3). This raised
the question as to how CTL recognize EBV-infected B-lympho
cytes and how, on the other hand, BL cells can avoid being
recognized. Virus-specific CTL usually recognize viral struc
tures on the surface of infected cells. To date two EBV-coded
proteins produced in latently infected cells are known as targets
for CTL: the membrane protein encoded by the reading frame
BNLF1 (BNLF1-MA), often denoted as latent membrane an
tigen (4, 5), and one component of the EBNA complex, EBNA
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3 (6). In BL cells the BNLF1-MA is present only in reduced
amounts in a truncated version (7, 8) and, therefore, probably
does not function as a target for CTL; EBNA 3, however, is
usually expressed in BL cells (9) and should be recognized.
Recently, Torsteinsdottir et al. (10) demonstrated that certain
BL cells were not only resistant to EBV-specific HLA-matched
CTL but also to allospecific CTL. Thus, apart from the lack of
viral antigens there must be another mechanism rendering BL
cells resistant to specific CTL, possibly an alteration in the
expression of class I antigens of the MHC which present
processed viral antigen to CTL. Data in the literature about
class I antigens at the surface of EBV-infected cells are in part
contradictory (3, 10-14); we therefore decided to study the
expression of these structures in more detail using EBV-infected
LCLs and BL cells and, in comparison, EBV-negative BL cells,
resting B-cells, and pokeweed mitogen-stimulated B-blasts.
MATERIALS AND METHODS
Cell Lines. BL lines were established by direct outgrowth from tumor
biopsies; LCLs were generated from peripheral B-cells of BL patients
or healthy donors, either by spontaneous outgrowth or by in vitro
infection with the B95-8 strain of EBV. The BL lines studied were the
EBV-positive lines Jijoye, P3HR1, Daudi, Nawalma, and Raji, the
EBV-negative line BJAB, and its subline BJAB/B95-8 which was
converted to the EBV-positive status. The eight pairs of BL lines and
corresponding LCLs from the same patients were kindly provided by
G. Lenoir, Lyon, France (BL 2/LCL 304, BL 29/LCL 167, BL 36/
LCL 174, BL 64/LCL 549, BL 67/LCL 309) and A. Rickinson,
Birmingham, United Kingdom (WEW BL/LCL, ELI BL/LCL, CHEP
BL/LCL) and have been described in detail elsewhere (15, 16). Cells
were maintained in RPMI 1640 supplemented with 2 HIMglutamine
and 10% fetal calf serum containing 100 IU/ml penicillin and 100 //g/
ml streptomycin.
Antibodies. The monoclonal antibody W6/32, specific for a common
framework determinant of all class I molecules (17), was used for
radioimmunoassay and immunoprecipitation experiments. High titered
antisera against EBV-positive BL cells and LCLs were raised in rabbits.
Radioimmunoassay for Quantitative Analysis of Class I Antigens.
Cells (104/well in phosphate-buffered saline. pH 7.2, containing 0.5%
bovine serum albumin and 10 HIMsodium azide) were incubated for 2
h on ice in microtiter plates with monoclonal antibody W6/32 at
saturating levels. After the cells were washed '"I-labeled protein A
(Amersham, Braunschweig, FRG; ~100 000 cpm in 10 p\) was added
and after another 2 h incubation on ice the amount of bound radioac
tivity determined. In parallel experiments cells were incubated with a
saturating concentration of a mixture of two rabbit antisera directed
against EBV-positive BL cells and LCLs (anti-BL/LCL). In immuno
precipitation experiments this antiserum mixture recognized the vast
majority of exposed membrane proteins on BL cells, LCLs, and pe
ripheral B-cells. Radioactivity bound by anti-BL/LCL-treated cells was
considered to be a measure for the area of the cell surface accessible to
antibodies. The relative cell surface density of class I antigens was
calculated by dividing cpm obtained with W6/32 by cpm obtained with
anti-BL/LCL, times 100. This correction of the absolute number of
cpm obtained with the class I-specific antibody seemed necessary be
cause LCLs are often larger than BL cells; a calculation of the surface
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area from the diameter of the cells, however, is difficult because BL
cells possess more surface villi than LCLs (18). All samples were tested
in triplicate.
Analysis of Class I RNA. Total RNA was prepared from about 10s
lymphocytes using the guanidinium rhodanid/cesium chloride method
described by Maniatis et al. (19). Poly(A)* RNA was prepared from
100-500 Mgof total RNA by affinity chromatography on polyuridylate
paper (Hybond mAP; Amersham, Braunschweig, FRG) according to
the manufacturers' instructions. For Northern blot experiments stand
ard methods were used ( 19). Briefly, 10 /jg of total or 0.5 ng of poly(A)+
RNA was denatured in 50% formamide/2.2 M formaldehyde and elec-
trophoresed on a 2.2 M formaldehyde-containing agarose gel for 4-5
h. RNA was transferred to nylon filters (Biodyne, Pall BioSupport
division. New York) overnight. Slot blot analysis was performed using
a Minifold II apparatus (Schleicher and SchÃ¼ll,Dassel, FRG). Total(10 fig) or poly(A)* RNA (0.5 j*g)was denatured in glyoxal and spotted
on nitrocellulose. Filters were hybridized using standard conditions
(19) with a human HLA complementary' DNA probe (kindly provided
by E. Weiss, Munich, FRG) labeled with "P by means of a commercially-
available nick-translation kit (Boehringer-Mannheim. Mannheim,
FRG). For quantitation of RNA autoradiographs were scanned using
an Elscript densitometer (Hirschmann, Munich, FRG) and the relative
densities of specific RNA in BL cells and LCLs were compared directly.
Analysis of Class I Antigens by One- and Two-Dimensional Gel
Electrophoresis. lodination of cell surface proteins was done exactly as
described by Hubbard and Cohn (20). Cells were metabolically labeled
in the presence of 250 Â¿iCi("S|methionine for 12 h. Lysis of labeled
cells and immunoprecipitation was performed as described earlier (21).
Immunoprecipitates were either analyzed by SDS-polyacrylamide gel
electrophoresis or subjected to two-dimensional gel electrophoresis
according to the method of O'Farrell (22). Because LCLs usually
expressed higher amounts of class I antigens than BL cells, for a
qualitative comparison of the class I patterns of an LCL and the
corresponding BL line, immunoprecipitates of the two cell lines were
brought to equal specific radioactivity and equal amounts of radioactiv
ity were applied on the gel.
Induction of Class I Antigen Expression by -y-Interferon. Cells (2 x
10") were incubated with 0, 20, 200, or 2000 If/ml of recombinant 7-
interferon (kindly provided by F. J. Brzoska, Bioferon, Laupheim,
FRG). After 24, 48, and 72 h aliquots were removed and class I antigen
expression was determined by radioimmunoassay (see above). Results
were expressed as the ratio between the cpm values obtained for the
treated cells and the cpm values of the untreated control measured
simultaneously.
Miscellaneous. PBLs were isolated from heparinized blood by density
gradient centrifugation over Ficoll-Hypaque. B-lymphocytes were pre
pared from PBLs by removing T-cells by resetting with 2-aminoethy-
lisothiouromium bromide hydrobromide-treated sheep erythrocytes ac
cording to the method of Beverly (23). For the generation of B-blasts
PBLs were treated with pokeweed mitogen (10 Mg/ml; Gibco) for 5-7
days.
RESULTS
Density of Class I Antigens on LCLs and BL Cells. In prelim
inary experiments expression of class I antigens in the eight
pairs of BL lines and the corresponding LCLs from the same
patient was studied by immunoprecipitation of 125I-labeledclass
I proteins and analysis of the precipitated compounds by SDS-
gel electrophoresis followed by autoradiography. In five of these
pairs (BL 67/LCL 309, BL 2/LCL 304, ELI BL/LCL, CHEP
BL/LCL, BL 29/LCL 167) class I antigens were expressed in
clearly higher density on LCLs than on the corresponding BL
lines, as shown for two such pairs in Fig. 1. For quantitative
determination of class i antigen density a radioimmunoassay
was used; in addition to the eight BL/LCL pairs five commonly
used BL lines and five LCLs derived from healthy donors were
studied (Table 1).
MW
x10
,-3
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BL LCL BL LCL
67309 2 304
IMMUNOPREC.
Fig. I. Expression of MHC class I antigens on the surface of two pairs of BL
cells and corresponding LCLs from the same patients. To allow a comparison of
the density of class I antigens Nonidet P-40 (NP-40) extracts of labeled cells were
adjusted to equal amounts of radioactivity and corresponding immunoprecipitates
obtained with monoclonal antibody W6/32 were adjusted accordingly. Class I
antigens can clearly be identified even in Nonidet P-40 extracts (arrowheads),
although there is some interference with actin (*). The higher class I density in
both LCLs is clearly demonstrated as well as a qualitative difference in class I
antigens. MW. molecular weight.
The relative density varied considerably within the groups of
BL cells and LCLs; In general, however, LCLs showed a
significantly higher class I expression than BL cells (relative
densities, 48.3 versus 13.7, respectively; P < 0.001, Student's i
test).
A comparison of the eight BL/LCL pairs revealed an only
slightly higher class I density on LCLs for three pairs (WEW,
64/549, 36/174; ratios, 1.2-1.4), whereas in the remaining pairs
LCLs showed a 3.2- to 27.0-fold higher class I density than the
corresponding BL lines.
Analysis of Class I RNA. Northern blot hybridization of class
I RNA of six BL/LCL pairs with a class I-specific DNA probe
revealed one RNA species of about 2000 base pairs in both BL
and LCL cells (data not shown). A quantitative evaluation of
the expression of class I RNA in these six BL/LCL pairs by
slot blot hybridization showed in five pairs higher values of
specific RNA in LCLs than in BL cells; this effect was more
pronounced when poly(A)+ RNA was used (Table 2). However,
despite this general trend to higher class I RNA expression in
LCLs, there was in three pairs (67/309, 64/549, ELI) a clear
discrepancy between the LCL/BL ratio for RNA expression
and the expression of class I antigen.
Influence of â€¢y-Interferonon the Expression of Class I Anti
gens. BL/LCL pairs from two patients were incubated with
varying amounts of 7-interferon and the expression of class I
antigens was studied. A response was observed in both BL lines:
after 48 h of treatment the expression of class I antigens was
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Table 1 Levels of class 1 antigens on the surface ofBL cells and EBV-transformed LCLs as measured by radioimmunassay
Each cell line was tested at least twice, one representative experiment is shown.
P3HR1DaudiJijoyeNamalwaRajiBL67CWEW-Bl/BL64'BL2rELI-BL*BL36*CHEP-BL'BL29'Anti-class
I
(cpm)"1,8823742,8982,8382,2303,7933,37913,5075,1874645,6261,676435BL
cellsAnti-BL/LCL<cpm)Â°10,15921,99323,79321,37722,88828,63619,86928,15728.82120.10925,55835,58723,366Relative
density*18. 1.712.213.39.713.217.048.018.02.322.04.71.9Si-SWo-SMa-SPr-LCd-LLCL
309'WEW-LCL*LCL
549'LCL
304'EL1-LCLÂ«LCL
174*CHEP-LCL'LCL
167'Anti-class
I(cpm)Â°13,44414,32111.06016.51812,05817.9974.07630.54815.8155,3676.34032,12323,539LCLsAnti-BL/LCL(cpm)Â°31,63722.30823,96034,83836.15536,53719,938 6,71035,95327,67622,78425,33257,455Relativedensity*42.564.24 .247.433.449.320.4 5.444.019.4 .8127.041.0
" Mean of triplicate, after subtraction of background activity (no antibody added).
4(cpm obtained with anti-class 1 antibody)
(cpm obtained with anti-BL/LCL serum)
"J Pairs of corresponding BL cells and LCLs.
x 100.
Table 2 Relative amounts of class I-speciflc RNA in BL cells and corresponding
LCLs
Slot blot analysis of total (10 /Â¿g/Slot)and poly(A)* (0.5 Â»ig/slot)RNA;
autoradiograms were measured by densitometry and values given in arbitrary
units.
TotalRNABL/LCLpairs67/309WEW64/5492/304ELI36/174BL16.149.260.020.040.872.3LCL17.041.186.928.552.3100.0LCL/BL1.060.841.451.431.281.38Polv(A)*BL9.535.728.69.513.736.9LCL11.939.688.746.519.056.6RNALCL/BL1.251.113.104.901.391.53
24 48 72
5-1
4-
CL
O 2
BL 2
24 48 72
LCL 304
24 48 72 24 48 72
TIME OF INTERFERON TREATMENT (H)
Fig. 2. Influence of 7-interferon on the level of expression of class I antigens
on BL cells (left) and the corresponding LCLs (right). Class I antigen expression
was measured by radioimmunoassay; results are expressed relative to the values
obtained for the untreated cells (measured simultaneously) taken as a unit. Cpm
values for the untreated cells ranged from 1035 cpm (BL2) to 5622 cpm (LCL
309).
MW
xltf3
- 66
- 45
- 29
BL LCL BL LCL BL LCL BL LCL BL LCL BL LCL BL LCL
67 309 WEW 64 549 ELI 36 174 29 167 2 304
Fig. 3. SDS-gel electrophoresis of class I antigens of BL cells and correspond
ing LCLs. Class I antigens were precipitated from metabolically labeled cells
using monoclonal antibody W6/32. As far as possible equal amounts of radioac
tivity were applied. MW, molecular weight.
enhanced 3- to 5-fold, thus approaching the levels regularly
seen in corresponding LCLs. The treatment had no significant
influence on the latter (Fig. 2). The response to 7-interferon
was similar in both BL lines tested, irrespective of the presence
(BL 67) or absence (BL 2) of EBV.
Analysis of Class I Antigens by One- and Two-Dimensional
Gel Electrophoresis. Radioactively labeled class I antigens were
Â¡mmunoprecipitated and analyzed by gel electrophoresis. As
already assumed from the experiments shown in Fig. 1 one-
dimensional SDS-gel electrophoresis revealed clear differences
in the class I antigen pattern between the BL-cells and the
corresponding LCL in five of the seven cell pairs studied (67/
309, WEW, 64/549, ELI, 2/304) (Fig. 3). When cells were
labeled in the presence of tunicamycin to inhibit A'-linked
glycosylation, the two-dimemsiomal patterns changed but dif
ferences between BL cells and the corresponding LCL still
persisted, indicating that these differences are not caused by
altered glycosylation (data not shown).
The class I antigens of four cell pairs were further analyzed
by two-dimensional gel electrophoresis (Fig. 4). The cells of
pair 36/174 which did not show any class I antigen differences
in the one-dimensional analysis also showed an identical two-
dimensional pattern. In the BL cells of the three other pairs,
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BL 36
LCL 174
BL 67
LCL 309
BL 64
LCL 549
BL 2
LCL 304
BL LCL
Fig. 4. Two-dimensional gel electrophoresis of class I antigens of BL cells and
corresponding LCLs. Class I antigens were precipitated from metabolically la
beled cells using monoclonal antibody W6/32. The acidic end of the isoelectric
focusing gel is on the right. Equal amounts of radioactivity were applied.
Table 3 Influence of EBV infection on expression of class I antigens
Donor S.J.B-cellsB-blastsEBV
LCLsDonor
R.W.B-cellsB-blastsEBV
LCLsDonor
W.}.B-cellsB-blastsEBV
LCLsAnti-class
1(cpm)Â°1.0955.59810.26741812.95212.3631.1144,12011,588Anti-BL/LCL(cpm)Â°11,40718.51218.7607.00234,53530.1568,80212,89327.031Relativedensity49.630.254.76.037.541.012.732.042.9
' Mean of triplicate, after subtraction of background activity (no antibody
added).
,(cpm obtained with anti-class 1 antibody)
(cpm obtained with anti-BL/LCL serum) x 100.
however, one (67/309) or several (64/549, 2/304) spots were
not detected, which were clearly visible on the corresponding
LCLs. Conventional HLA typing of these four pairs showed
complete identity in the case of pair 36/174, whereas the BL
line 67 lacked HLA B 16 which was present on the LCL (309)
of this patient; BL 64 and BL 2 could not be typed because of
strong multispecific reactions.
Influence of EBV Infection on the Expression of Class I
Antigens. The influence of EBV infection on the expression of
class I antigens was studied in peripheral B-cells and in BL
cells which were originally EBV negative. Infection of isolated
B-lymphocytes with EBV led to a 3.4- to 6.8-fold increase in
class I expression; a similar effect was obtained by mitogenic
stimulation, i.e., B-blasts showed 2.5- to 6.3-fold higher values
(Table 3). Neither in LCLs nor in the EBV-infected BL cells,
^ PWM BLASTS
LCL
BJAB
BJAB B95-8
EBV-NEG EBV-POS
Fig. 5. Two-dimensional gel electrophoresis of class I antigens of pokeweed
mitogen (PWM) stimulated B-blasts and EBV-transformed LCLs of the same
individual (above) and of BJAB BL cells and their EBV-infected subline U.IMl
B95-8. Class I antigens were precipitated from metabolically labeled cells using
monoclonal antibody W6/32. The acidic end of the isoelectric focusing gel is on
the right. Equal amounts of radioactivity were applied.
however, did EBV infection change the pattern of class I spec
ificities as shown by two-dimensional gel electrophoresis (Fig.
5).
DISCUSSION
Several studies so far have dealt with the expression of class
I antigens of the MHC on BL cells and LCLs with, however,
somewhat conflicting results. Some authors described a high
class I expression on LCLs (11) and a low or even absent class
I expression on BL cells (12, 13, 24), whereas Rooney et al. (3)
and Torsteinsdottir et al. (10) did not observe significant differ
ences in class I expression in BL/LCL pairs. Down-regulation
of single class I specificities in BL cells was first described by
Masucci et al. (25), who found a selective loss of HLA AI l in
two BL lines resistant to AI l-restricted EBV-specific cytotoxic
T-cells; in two recent reports this could be extended to other
specificities as well (26, 27).
Our experiments demonstrate that the class I antigens of the
MHC are expressed differently on BL cells and on EBV-
transformed LCLs. Despite considerable individual variations,
LCLs in general revealed significantly higher class I levels than
BL cells; the latter showed a class I expression similar to or, in
the case of two lines (ELI BL, BL 29), considerably lower than
peripheral B-lymphocytes. The lines ELI BL and BL 29, in
fact, showed cpm values in the radioimmunoassay not much
higher then the BL line Daudi which is known to lack class I
antigens (13). These findings are in agreement with some earlier
studies (11, 12, 24) but conflict with the results of Rooney et
al. (3) and Torsteinsdottir et al. (10). The observed discrepan
cies might be caused by differences in the cell lines studied, but
more probably they are due to the different techniques used
[especially because four of the BL/LCL pairs of our study were
also analyzed by Rooney et al. (3)].
Our radioimmunoassay applies saturating antibody concen
trations (which was only possible by reducing the number of
cells/well to 1 x IO4) and uses a labeled second ligand of high
affinity ('"I-labeled protein A). This technique allows the de
tection of even small differences in class I density between
different cells, differences which might well remain undetecta-
ble under the conditions used by others (3, 10) who measured
class I expression by means of the fluorescence-activated cell
sorter.
In our study LCLs also showed, in general, a higher expres
sion of class I RNA than BL cells. However, there were some
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discrepancies between the class I RNA and the protein expres
sion: two pairs showed low differences in RNA expression but
high differences in antigen expression; the opposite was found
in another pair. Thus, although one might assume that the
differences in the expression of these antigens might be due to
different expression on the transcriptional level, these data do
not fully support this idea. On the other hand, such a mecha
nism would well correspond with our finding that 7-interferon
increases class I antigen expression on both of the BL lines
studied because 7-interferon is known to enhance transcription
of MHC antigens in other cells (28). Thus, according to our
results it is very likely that the down-regulation of class I
expression occurs at the transcriptional level but this has to be
definitely proven by further experiments. Interestingly, the
treatment with 7-interferon did not alter class I expression in
the two LCLs; therefore, in the latter class I antigens seem to
be maximally expressed.
The qualitative variations in the pattern of class I specificities
seen in the two-dimensional gel electrophoresis experiments
point strongly to down-regulation of certain class I specificities
in three of the four BL lines studied. This technique cannot
rule out completely that in BL cells only modifications of class
I antigens are missing, e.g., molecules differing in their carbo
hydrate content; however, because differences between BL lines
and LCLs were still present after treatment with tunicamycin,
and because in two of the BL lines four or even five spots seen
in the corresponding LCLs were missing, the most probable
explanation would indeed be the lack of expression of one or,
in the case of BL 2 and BL 64, even more class I specificities.
These results are in accordance with the studies (25-27) which
demonstrated down-regulation of HLA AI l in certain BL cells
by means of specific monoclonal antibodies. In addition our
study shows for two BL lines (ELI, BL 29) a complete down-
regulation of all (or at least most) class I specificities far below
the level seen in resting B-lymphocytes.
All of the observed differences in class I expression (the
quantitative variations between LCLs and the corresponding
BL lines or the normal resting B-lymphocytes, as well as the
down-regulation of certain class I specificities in BL cells)
turned out to be independent of infection with EBV. Mitogenic
stimulation of peripheral B-cells led to a significant increase in
class I expression similarly to the effect of EBV infection; the
two-dimensional gel electrophoresis pattern of class I antigens
of normal B-lymphocytes was not altered by EBV infection.
Similarly, infection of the EBV-negative line BJAB did not
influence the pattern of class I expression. On the other hand,
down-regulation of some class I antigens was found also in the
EBV-negative BL line BL 2. Thus, the alteration of class I
expression in BL cells [down-regulation of some (BL 67, BL
64, BL 2) or obviously all (ELI BL, BL 29) class one specifici
ties] seems to be linked mainly to the tumorigenic nature of
these cells.
Altered MHC class I antigen expression is a well-known
phenomenon in several tumors such as malignant melanoma
(29), colorectal carcinoma (30), certain B-cell lymphomas (31),
small cell lung cancer (32), and neuroblastoma (33). For the
latter system Bernards et al. (34) recently showed that down-
modulation of class I antigens is a consequence of overexpres-
sion of the cellular oncogene N-myc. Such a mechanism may
prove true for BL cells as well in which the typical chromosomal
translocations (35) are thought to lead to a deregulated expres
sion of c-myc; overexpression of c-myc may cause down-regu
lation of class I antigens.
It is tempting to assume that reduced class I expression
influences the recognition of BL cells by specific cytotoxic T-
cells. In EBV-infected cells viral structures should play the
definitive role in their recognition by specific CTL; the reduced
expression or the complete lack of viral target structures as the
BNLF1-MA (4, 7) is thought to be a main mechanism involved
in BL cells escaping immune surveillance. Nevertheless, cellular
factors may be important as well. Gregory et al. (36) recently
showed that the down-regulation of cell adhesion molecules
paralleled the ability of BL cells to escape the attack by CTL.
On the other hand, Masucci et al. (25) could clearly demonstrate
that the selective lack of HLA All in two EBV-positive BL
lines prevented their killing by EBV-specific CTL, thus shed
ding light on the role of class I antigens in the immune recog
nition of these cells. It may well be that several factors, viral
and cellular, contribute to the resistance of BL cells to cellular
immune attacks. Our data show that down-regulation of all or
single class I antigens in BL cells seems to be a rather frequent
event. The overexpression of these structures observed in LCLs,
on the other hand, may well render these cells more susceptible
to specific lysis and, therefore, play a role in the effective control
of EBV-transformed lymphocytes.
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